Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Jenny-Kay Sharpe, Terry J Stedman, Nuala M Byrne, Connie Wishart, Andrew P Hill. Energy expenditure and physical activity in clozapine use: implications for weight management. The Australian and New Zealand journal of psychiatry. vol 40. issue 9. 2006-12-20. PMID:16911758. |
the current study of men with schizophrenia taking clozapine aimed to measure total energy expenditure (tee) and energy expended on physical activity--activity energy expenditure (aee) and to consider the clinical implications of the findings. |
2006-12-20 |
2023-08-12 |
Not clear |
W W Blessing, A Zilm, Y Ootsuk. Clozapine reverses increased brown adipose tissue thermogenesis induced by 3,4-methylenedioxymethamphetamine and by cold exposure in conscious rats. Neuroscience. vol 141. issue 4. 2006-12-04. PMID:16814930. |
clozapine's marked inhibition of ibat thermogenesis may provide a clue to its marked tendency to cause obesity when used to treat humans with mental disorders including schizophrenia. |
2006-12-04 |
2023-08-12 |
rat |
T Tényi, V Vörö. Successful switch to olanzapine after rhabdomyolysis caused by water intoxication and clozapine use. Pharmacopsychiatry. vol 39. issue 4. 2006-11-30. PMID:16871473. |
the 46-year-old patient with the diagnosis of schizophrenia paranoid type, who had been on clozapine treatment for the previous 4 years, was admitted with the symptoms of generalized seizure and vomiting, and as severe hyponatremia was proved, its correction with the parallel use of clozapine treatment was done. |
2006-11-30 |
2023-08-12 |
Not clear |
Ana Maria Sertori Durão, Maria Conceição Bernardo de Mello e Souz. [Schizophrenia patients' daily life after the use of clozapine and group accompaniment: Family's view]. Revista latino-americana de enfermagem. vol 14. issue 4. 2006-11-03. PMID:16967166. |
[schizophrenia patients' daily life after the use of clozapine and group accompaniment: family's view]. |
2006-11-03 |
2023-08-12 |
Not clear |
Ana Maria Sertori Durão, Maria Conceição Bernardo de Mello e Souz. [Schizophrenia patients' daily life after the use of clozapine and group accompaniment: Family's view]. Revista latino-americana de enfermagem. vol 14. issue 4. 2006-11-03. PMID:16967166. |
this study described the daily life of schizophrenia patients after the use of clozapine and group accompaniment from the perspective of family members. |
2006-11-03 |
2023-08-12 |
Not clear |
Ana Maria Sertori Durão, Maria Conceição Bernardo de Mello e Souz. [Schizophrenia patients' daily life after the use of clozapine and group accompaniment: Family's view]. Revista latino-americana de enfermagem. vol 14. issue 4. 2006-11-03. PMID:16967166. |
the research population consisted of 11 family members who most frequently accompanied 11 schizophrenia patients who participate in the group and use clozapine. |
2006-11-03 |
2023-08-12 |
Not clear |
Hsien-Yuan Lane, Chieh-Liang Huang, Po-Lun Wu, Yi-Ching Liu, Yue-Cune Chang, Pao-Yen Lin, Po-Wei Chen, Guochuan Tsa. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. Biological psychiatry. vol 60. issue 6. 2006-11-01. PMID:16780811. |
glycine transporter i inhibitor, n-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. |
2006-11-01 |
2023-08-12 |
Not clear |
Branimir Margetić, Branka Aukst-Margetić, Tija Zarković-Palija. Successful treatment of polydipsia, water intoxication, and delusional jealousy in an alcohol dependent patient with clozapine. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 7. 2006-10-31. PMID:16600455. |
the beneficial effect of clozapine on polydipsia and water intoxication in patients with schizophrenia has been demonstrated many times. |
2006-10-31 |
2023-08-12 |
Not clear |
Daniel J Luchin. In the aftermath of CATIE: how should administrators value atypical antipsychotic medications? Administration and policy in mental health. vol 33. issue 5. 2006-10-31. PMID:16688482. |
although there is evidence that the atypical antipsychotic, clozapine, may lead to cost savings in patients with refractory schizophrenia the cost-effectiveness of the other atypical antipsychotics remains in question. |
2006-10-31 |
2023-08-12 |
Not clear |
S W Lewis, L Davies, P B Jones, T R E Barnes, R M Murray, R Kerwin, D Taylor, K P Hayhurst, A Markwick, H Lloyd, G Dun. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Health technology assessment (Winchester, England). vol 10. issue 17. 2006-10-26. PMID:16707074. |
randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. |
2006-10-26 |
2023-08-12 |
Not clear |
Mohamed Sabaawi, Nirbhay N Singh, Jose de Leo. Guidelines for the use of clozapine in individuals with developmental disabilities. Research in developmental disabilities. vol 27. issue 3. 2006-10-25. PMID:16040229. |
we present a set of guidelines to ensure proper utilization of clozapine in individuals with developmental disabilities, because it can offer them therapeutic advantages similar to those observed in people with schizophrenia. |
2006-10-25 |
2023-08-12 |
Not clear |
Mansour Razminia, Yasser Salem, Sivasubramaniam Devaki, Nilamben Shah, Sandeep Khosl. Clozapine induced myopericarditis: early recognition improves clinical outcome. American journal of therapeutics. vol 13. issue 3. 2006-10-19. PMID:16772769. |
clozapine is an atypical dibenzodiazepine antipsychotic used for resistant schizophrenia. |
2006-10-19 |
2023-08-12 |
Not clear |
Narsimha R Pinninti, Catherine J Datt. Cognitive behavior therapy and clozapine synergy in an older adult with schizophrenia? The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 14. issue 8. 2006-10-13. PMID:16864560. |
cognitive behavior therapy and clozapine synergy in an older adult with schizophrenia? |
2006-10-13 |
2023-08-12 |
Not clear |
L N Gorobets, L G Ermolaeva, A V Litvino. [Reproductive dysfunctions in female patients during therapy with atypical antipsychotics]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 106. issue 8. 2006-10-10. PMID:16972595. |
to specify interrelations between clinical and hormonal aspects of reproductive dysfunctions appearing during therapy with atypical antipsychotic agents (clozapine, olanzapine, quetiapine), 131 female patients with paranoid schizophrenia and schizoaffective disorder have been studied. |
2006-10-10 |
2023-08-12 |
Not clear |
Christina Kurre Olsen, Mads Kreilgaard, Michael Didrikse. Positive modulation of glutamatergic receptors potentiates the suppressive effects of antipsychotics on conditioned avoidance responding in rats. Pharmacology, biochemistry, and behavior. vol 84. issue 2. 2006-10-05. PMID:16782180. |
concordantly, augmentation of the nmda receptor function by glycine-site agonists such as d-serine and d-cycloserine has been reported to improve negative symptoms and some cognitive deficits in schizophrenia patients when added to conventional antipsychotic treatment, although they appear less effective when combined with clozapine specifically. |
2006-10-05 |
2023-08-12 |
rat |
Christina Kurre Olsen, Mads Kreilgaard, Michael Didrikse. Positive modulation of glutamatergic receptors potentiates the suppressive effects of antipsychotics on conditioned avoidance responding in rats. Pharmacology, biochemistry, and behavior. vol 84. issue 2. 2006-10-05. PMID:16782180. |
in contrast, administration of the ampakine cx-516 (which positively modulate the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (ampa) receptor) as an adjuvant to clozapine, has been shown to exert some beneficial action on the negative symptoms and cognitive deficits in schizophrenia. |
2006-10-05 |
2023-08-12 |
rat |
Marc Ziegenbein, Iris T Callies. Clozapine and ziprasidone: a useful combination in patients with treatment-resistant schizophrenia. The Journal of neuropsychiatry and clinical neurosciences. vol 18. issue 2. 2006-09-28. PMID:16720806. |
clozapine and ziprasidone: a useful combination in patients with treatment-resistant schizophrenia. |
2006-09-28 |
2023-08-12 |
Not clear |
Avril Pereira, Brian Dea. Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosis. Biochemical pharmacology. vol 72. issue 6. 2006-09-26. PMID:16844094. |
clozapine, an atypical antipsychotic drug effective in treatment of refractory schizophrenia causes potentially life-threatening agranulocytosis. |
2006-09-26 |
2023-08-12 |
human |
Philip J Tyson, Keith R Laws, Kenneth A Flowers, Agi Tyson, Ann M Mortime. Cognitive function and social abilities in patients with schizophrenia: relationship with atypical antipsychotics. Psychiatry and clinical neurosciences. vol 60. issue 4. 2006-09-20. PMID:16884450. |
comparisons were done for matched schizophrenia patients who were on antipsychotics with (i) an affinity for multiple receptors (olanzapine, clozapine, quetiapine) versus those that have preferential affinity for dopamine receptors (risperidone, amisulpride); and patients on medication with (ii) a high affinity for serotonin (5ht-2a) receptors (risperidone, olanzapine, clozapine) versus those with a low (or no) affinity for 5ht-2a receptors (quetiapine, amisulpride). |
2006-09-20 |
2023-08-12 |
Not clear |
Ying-Qiang Xiang, Zhang-Jin Zhang, Yong-Zhen Weng, Yi-Min Zhai, Wen-Biao Li, Zhuo-Ji Cai, Qing-Rong Tan, Chuan-Yue Wan. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia. Schizophrenia research. vol 83. issue 2-3. 2006-09-19. PMID:16524698. |
serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia. |
2006-09-19 |
2023-08-12 |
human |